We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+3.87%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.81B
AUM Growth
-$531M
Cap. Flow
-$1.18B
Cap. Flow %
-24.44%
Top 10 Hldgs %
18.16%
Holding
673
New
167
Increased
91
Reduced
97
Closed
256

Top Buys

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$59.4M
2
ONXX
ONYX PHARMACEUTICALS INC
ONXX
+$56.3M
3
SPG icon
Simon Property Group
SPG
+$52M
4
TSM icon
TSMC
TSM
+$45.4M
5
M icon
Macy's
M
+$44.3M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$167M
2
GDI
GARDNER DENVER,INC
GDI
+$60.4M
3
BMC
BMC SOFTWARE, INC
BMC
+$58.7M
4
SFD
SMITHFIELD FOODS,INC
SFD
+$55.2M
5
AAP icon
Advance Auto Parts
AAP
+$48.2M

Sector Composition

Rank Sector Weight
1 Real Estate 14.75%
2 Consumer Staples 11.78%
3 Consumer Discretionary 6.16%
4 Financials 6.01%
5 Industrials 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBY icon
376
Best Buy
BBY
$16.9B
– –
-289,645
Closed -$7.92M
BBY icon
377
PUT
Best Buy
BBY
$16.9B
– –
-1,000,000
Closed -$45K
BIIB icon
378
Biogen
BIIB
$30.5B
– –
-36,000
Closed -$7.75M
BNY
379
PUT
Bank of New York Mellon
BNY
$108B
– –
-125,000
Closed -$90K
BMRN icon
380
BioMarin Pharmaceuticals
BMRN
$11.9B
– –
-47,000
Closed -$2.62M
BMY icon
381
Bristol-Myers Squibb
BMY
$131B
– –
-107,000
Closed -$4.78M
BRC icon
382
Brady Corp
BRC
$4.63B
– –
-51,972
Closed -$1.6M
CAG icon
383
Conagra Brands
CAG
$7.11B
– –
-1,294,639
Closed -$35.2M
CAT icon
384
PUT
Caterpillar
CAT
$394B
– –
-115,000
Closed -$300K
CDP icon
385
COPT Defense Properties
CDP
$4.22B
– –
-421,676
Closed -$10.8M
CF icon
386
CF Industries
CF
$17.7B
– –
-98,230
Closed -$3.37M
CI icon
387
Cigna
CI
$72.7B
– –
-103,583
Closed -$7.51M
CIM
388
Chimera Investment
CIM
$993M
– –
-107,170
Closed -$4.82M
CLX icon
389
PUT
Clorox
CLX
$12.8B
– –
-300,000
Closed -$545K
CMA
390
PUT
DELISTED
Comerica
CMA
– –
-250,000
Closed -$239K
CMCSA icon
391
Comcast
CMCSA
$89.3B
– –
-100,000
Closed -$2.09M
CNC icon
392
Centene
CNC
$31.7B
– –
-80,000
Closed -$1.05M
COF icon
393
Capital One
COF
$135B
– –
-401,254
Closed -$25.2M
COST icon
394
Costco
COST
$421B
– –
-352,264
Closed -$39M
CP icon
395
Canadian Pacific Kansas City
CP
$79.3B
– –
-421,405
Closed -$10.2M
CPB icon
396
CALL
Campbell Soup
CPB
$6.73B
– –
-100,000
Closed -$20K
CSCO icon
397
Cisco
CSCO
$476B
– –
-125,000
Closed -$3.04M
CTSH icon
398
CALL
Cognizant
CTSH
$25.6B
– –
-196,400
Closed -$73K
CYH icon
399
Community Health Systems
CYH
$416M
– –
-24,200
Closed -$938K
DAN icon
400
Dana Inc
DAN
$2.94B
– –
-209,627
Closed -$4.04M
14 15
16
17 18

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q3 2013 Portfolio in Review

As of Q3 2013, UBS O'Connor held 673 positions worth $4.81B, down 9.9% from $5.34B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS O'Connor withdrew a net $1.18B in Q3 2013, closing 256 positions and reducing 97 holdings. Its most notable exit was Pfizer, an estimated $167M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 15% of assets, up from 13% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, UBS O'Connor opened a new position in Colgate-Palmolive worth $59.4M.

  • UBS O'Connor's largest Q3 2013 buy was Colgate-Palmolive: 1,002,498 shares worth $59.4M.
  • UBS O'Connor added most to ONYX PHARMACEUTICALS INC in Q3 2013, an estimated $56.3M increase.
  • UBS O'Connor's biggest Q3 2013 reduction was Advance Auto Parts, cutting an estimated $48.2M.
  • UBS O'Connor fully exited Pfizer in Q3 2013, selling an estimated $167M.
  • UBS O'Connor's ten largest holdings make up 18% of its $4.81B portfolio in Q3 2013.
  • UBS O'Connor opened 167 new positions and closed 256 in Q3 2013.
  • UBS O'Connor's portfolio value fell 9.9% quarter-over-quarter to $4.81B.

Based on UBS O'Connor's 13F filing for Q3 2013, filed 14 Nov 2013.